PMID- 21336255 OWN - NLM STAT- MEDLINE DCOM- 20110824 LR - 20220421 IS - 1476-5454 (Electronic) IS - 0950-222X (Print) IS - 0950-222X (Linking) VI - 25 IP - 5 DP - 2011 May TI - Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. PG - 633-41 LID - 10.1038/eye.2011.34 [doi] AB - PURPOSE: The purpose of this study was to explore the relation between age at menarche, parity, and oral contraceptive (OC) use, and primary open-angle glaucoma (POAG). METHODS: We followed 79 440 women in the Nurses' Health Study prospectively from 1980 to 2006 and identified 813 cases of incident POAG. Eligible participants were >/=40 years old, free of POAG at baseline, had information on reproductive history, and reported receiving eye examinations during follow-up. Relevant exposure data and POAG risk factors were updated using biennial questionnaires. We used proportional hazards models to calculate multivariable rate ratios (MVRRs) of POAG and 95% confidence intervals (CI). RESULTS: In multivariable analysis, there were no significant linear trends between age at menarche (P for trend=0.65) or reproductive duration defined as time between age at menarche and menopause (P for trend=0.30) and POAG. Although ever using OCs was not associated with POAG risk (MVRR=1.14; 95% CI, 0.98, 1.34), >/=5 years of OC use was associated with a modest 25% increased risk of POAG (MVRR=1.25; 95% CI, 1.02, 1.53; P for linear trend=0.04). Furthermore, among past OC users, a shorter time since stopping OC use was also associated with an increased risk of POAG (P for linear trend=0.02). Parity was not associated with POAG risk. CONCLUSION: The >/=5 years of OC use was associated with a modestly increased risk of POAG. These data add further support for a role of circulating estrogen in the pathogenesis of POAG. FAU - Pasquale, L R AU - Pasquale LR AD - Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Brigham and Women's Hospital, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA. Louis_Pasquale@meei.harvard.edu FAU - Kang, J H AU - Kang JH LA - eng GR - P01 CA087969/CA/NCI NIH HHS/United States GR - EY015473/EY/NEI NIH HHS/United States GR - P01 CA055075/CA/NCI NIH HHS/United States GR - CA87969/CA/NCI NIH HHS/United States GR - R01 EY015473-07/EY/NEI NIH HHS/United States GR - CA55075/CA/NCI NIH HHS/United States GR - EY09611/EY/NEI NIH HHS/United States GR - R01 EY015473/EY/NEI NIH HHS/United States GR - R01 HL035464/HL/NHLBI NIH HHS/United States GR - HL35464/HL/NHLBI NIH HHS/United States GR - R01 EY009611/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110218 PL - England TA - Eye (Lond) JT - Eye (London, England) JID - 8703986 RN - 0 (Contraceptives, Oral) SB - IM MH - Adult MH - Age Factors MH - Contraceptives, Oral/administration & dosage MH - Female MH - Glaucoma, Open-Angle/*epidemiology MH - Humans MH - Incidence MH - Menarche MH - Menopause/physiology MH - Menstrual Cycle/*physiology MH - Middle Aged MH - Multivariate Analysis MH - Nurses MH - Parity MH - Pregnancy MH - Prospective Studies MH - *Reproductive History MH - Risk Factors MH - Surveys and Questionnaires PMC - PMC3093442 MID - NIHMS269271 EDAT- 2011/02/22 06:00 MHDA- 2011/08/25 06:00 PMCR- 2012/05/01 CRDT- 2011/02/22 06:00 PHST- 2011/02/22 06:00 [entrez] PHST- 2011/02/22 06:00 [pubmed] PHST- 2011/08/25 06:00 [medline] PHST- 2012/05/01 00:00 [pmc-release] AID - eye201134 [pii] AID - 10.1038/eye.2011.34 [doi] PST - ppublish SO - Eye (Lond). 2011 May;25(5):633-41. doi: 10.1038/eye.2011.34. Epub 2011 Feb 18.